Hong Kong stocks fluctuate | The decline of innovative drug concept stocks expands, Trump says he will quickly impose tariffs on drugs, and Goldman Sachs predicts a low possibility of taxing BD.

According to the Securities Times app, the concept stocks of innovative drugs fell further in the afternoon. As of the time of publication, China Medical System (01801.HK) fell by 5.3% to 94.65 Hong Kong dollars; Innovent Biologics (09969.HK) fell by 3.72% to 17.35 Hong Kong dollars; Sinopharm Group (03933.HK) fell by 3.03% to 16.31 Hong Kong dollars; and Hutchison China MediTech Ltd. (00013) fell by 1.98% to 24.74 Hong Kong dollars.